Target intelligence / Profile preview

Extracellular matrix (Dermal collagen network) (ECM)

Target
ECM
Molecular classification
Other
01

Overview

The extracellular matrix (ECM) of the dermis is a sophisticated structural network composed primarily of Type I and Type III collagen fibers, elastin, and a ground substance of glycosaminoglycans and proteoglycans (Frantz et al., 2010, Journal of Cell Science). This network provides the skin with essential mechanical properties, including tensile strength, resilience, and elasticity, while also acting as a reservoir for growth factors and a scaffold for cell-matrix interactions (StatPearls, 2023). In clinical practice, the dermal collagen network is a major therapeutic target for addressing skin aging, wound healing, and various fibrotic conditions (Varani et al., 2006, American Journal of Pathology). Pharmacological interventions, such as topical retinoids, aim to enhance collagen density by stimulating fibroblast activity and suppressing the expression of collagen-degrading matrix metalloproteinases (MMPs). In contrast, therapeutic enzymes like collagenase are utilized to break down excessive or pathological collagen deposits in conditions such as Dupuytren's contracture (FDA, 2010). The integrity and organization of this network are critical biomarkers for skin health and are frequently monitored in dermatological research and cosmetic development.

Other names
Dermal matrixInterstitial matrixConnective tissue matrixDermal collagen
02

Mechanism of action

Modulation of collagen synthesis via fibroblast activation, inhibition of matrix metalloproteinases (MMPs), or direct enzymatic proteolysis of collagen fibers.

03

Biological functions

OtherSignal transductionCell adhesionTissue repair
04

Disease associations

OtherInflammation
05

Safety considerations

FibrosisTissue atrophyImmunogenicityInjection site reactions
06

Interacting drugs

Tretinoin

3 more in the full profile.

07

Biomarkers

Procollagen type I N-terminal propeptide (PINP)Matrix metalloproteinase-1 (MMP-1)Carboxy-terminal telopeptide of type I collagen (ICTP)

Beyond the preview

Go deeper on Extracellular matrix (Dermal collagen network) (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix (Dermal collagen network) (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call